Extensive-stage Small-cell Lung Cancer trials recruiting in California

All Extensive-stage Small-cell Lung Cancer trials nationally

Cities in California

Recruiting trials in California

• A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
  NCT07005128 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female) · California: Fullerton, Los Angeles, Santa Monica, Whittier
• A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
  NCT06362252 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles, Newport Beach
• A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC
  NCT07459634 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles
• A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)
  NCT07037758 · Phase: Phase 1 · Ages: 18 Years to 90 Years · Sex: All (male and female) · California: Los Angeles
• Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases
  NCT05588388 · Phase: Phase 2 · Ages: No age limits stated · Sex: All (male and female) · California: Los Angeles
• Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
  NCT06598306 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles